UBS Oconnor LLC

SEC CIK: 0001132716
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

AMLX holding history

Amylyx Pharmaceuticals, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMLX overview All 13F holders of AMLX Full Q4 2025 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of AMLX by UBS Oconnor LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−35,000−100.0%	Sold out	Holders
Q3 2023	35,000	$640.9K	<0.1%	−4,000−10.3%	Reduced	Holders
Q2 2023	39,000	$841.2K	<0.1%	+39,000	New	Holders